Unseen cancer revealed
The New Generation of Assessment
Developing AI-Enabled Optical Detection Systems for Tumor Margin Assessment and Tissue Characterization
When it comes to cancer treatment, even the smallest amount of leftover tissue can lead to recurrence. Reveal combines an AI engine that provides real-time tissue diagnostics, sophisticated optical techniques, and an intuitive probe that can be manipulated easily during surgery. We give world-class surgeons the ability to confidently identify previously undetected cancerous tissue in vivo, giving patients a greater chance at a healthier life.
Our Technology
Optical Imaging Technology For Tumor Assessment
Surgeons are often faced with critical decisions in real-time. With little margin for error, greater tumor cell identification and precise excision are key – remove too little tissue and risk fatal recurrences or remove too much and cause profound neurological damage. Learn more about how Reveal’s technology is tackling this problem.
Our technology allows surgeons to safely and precisely remove more cancer than current imaging modalities – ultimately leading to better outcomes for patients.
Sentry’s ability to characterize tissue in vivo – while in surgery – is a game-changer. Surgeons can gain clarity on the type of tissue they’re investigating simply by applying an optical tool to the area in question. The power behind this probe is an AI engine that provides real-time tissue diagnostics.
Team REVEAL SURGICAL
management
BOARD ADVISor
